Sept. 20, 2011—The Food and Drug Administration (FDA) will host a free public workshop Oct. 25 & 26 on magnetic resonance imaging (MRI) safety. The purpose of the workshop is to discuss factors affecting the safe use of MRI and approaches to risk mitigation. The overall goal is to discuss strategies to minimize patient and staff risk in the MRI environment. The topics to be discussed are: general MRI safety, ferromagnetic detectors, scanning patients with medical implants, and the impact of innovation on MRI safety concerns.
Requests for Oral Presentations
This workshop includes public comment and topic-focused roundtable sessions. During on-line registration you may indicate if you wish to present in person during a public comment session or participate in a roundtable session, and which topics you wish to address. FDA will do its best to accommodate requests to make public comment.
Individuals and organizations with common interests are urged to consolidate or coordinate their presentations, and request time for a joint presentation, or submit requests for designated representatives to participate in the roundtable. All requests to make oral presentations must be received by the close of registration on October 4, 2011. If selected for presentation, any presentation materials must be sent by email to the Contact Person no later than October 11, 2011. No commercial promotional material will be permitted to be presented or distributed at the workshop.
There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. If you wish to attend this Workshop, you must register by 5 pm EDT on October 4, 2011. Early registration is recommended because facilities are limited and, therefore, FDA may limit the number of participants from each organization. Click here for more information and to register.